Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers

Christopher A. Demerson, Leslie G. Humber, N. A. ABRAHAM, G. Schilling, R. R. Martel, C.R. Pace-Asciak

Journal of Medicinal Chemistry · 1983 · 93 citations · 0 references

Concepts

Abstract

Etodolac, 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid, a clinically effective analgesic and antiinflammatory agent, has been resolved via a chromatographic separation of its diastereoisomeric esters with (-)-borneol. The effects of the enantiomers were studied in vitro on prostaglandin synthetase and on adjuvant-induced arthritis in rats. The biochemical and pharmacological results show that virtually all of the effects of etodolac are due to the (+) enantiomer.